Todd Anderman, CLO of Ocular Therapeutix OCUL, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $137.4K. The latest trade was on 01/02.

TA

TA

Todd Anderman

Chief Legal Officer

Company

Ocular Therapeutix OCUL

First filing

24/10/09

Trades

5 trades

Buys / sales

0 / 1

12-month net buying

−$137.4K

Last trade

01/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Ocular TherapeutixOCUL	Open-market sale10b5-1 plan	25/10/08	25/10/10	11,132 sh	$12.34	$137,368.88	−11.3%